- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05973565
The Effects of a Single Session of Rhythmic Movement Program on Selected Biopsychological Parameters in PD Patients
The Effects of a Single Session of Rhythmic Movement Program on Selected Biopsychological Parameters in PD Patients: A Methodological Approach.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
West Midlands
-
Walsall, West Midlands, United Kingdom, WS1 3BD
- University of Wolverhampton
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Hoehn and Yahr (H&Y) Parkinson disease scale I-III
- No restriction on disease duration,
- No restriction on type of drug therapy
- Stable antiparkinsonian medication of at least 6 months
- Data collections will be "on" medication
- No participation to any other exercise program for at least 2 months
- 100% attendance of the session.
Exclusion Criteria:
- Dementia
- Deep brain stimulation,
- Cancer,
- Cardiovascular diseases
- Poor visual capability
- Poor or auditory capability
- Musculoskeletal problems
- No stable antiparkinsonian therapy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: synchronous learning format
Volunteers will be asked to attend synchronous learning format MSK Training.
The exercise protocol has a duration of 45 minutes of rhythmic training and includes sections of warming-up, stretching, breathing, movement combinations, a dance sequence and recovery.
Each exercise is accompanied with music that provides a clear and predictable rhythm.
More specifically, the beat or rhythm of the music is used as a guide for the timing and duration of specific movements, allowing people with PD to coordinate their movements with the music.
Simple values are going to be introduced such as whole notes, half notes and quarter notes; clapping and tapping, breathing and sounds.
Class will be accompanied by recorded classical piano music, to meet the needs of synchronous learning format and asynchronous remote video-based format.
The intensity of the class is moderate approximately 3 MET.
The instructor is an experienced dance teacher in musicokinetic education.
|
The intervention protocols are either a) synchronous learning format, b) asynchronous remote video- based, and c) control.
|
|
Experimental: Asynchronous remote video-based format
Volunteers will be asked to attend asynchronous remote video-based format MSK Training. The exercise protocol is the same as the synchronous format but delivered via a video-based format |
The intervention protocols are either a) synchronous learning format, b) asynchronous remote video- based, and c) control.
|
|
No Intervention: Control
Volunteers will not be asked to sit quietly for a 45-minute period
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety
Time Frame: 1-2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
|
Hamilton Anxiety rating scale.
Scores of 17 or less indicates mild anxiety severity, 18 to 24 indicates mild to moderate anxiety severity, and 25 to 30 indicates a moderate to severe anxiety severity.
|
1-2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
|
|
Dorsolateral pre-frontal cortex (DLPFC) blood markers during gait
Time Frame: 2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
|
A portable fNIRS system (Portalite, Artinis Medical Solutions, Netherlands) will be applied to monitor concentration changes (mM), of O2Hb, HHb and total hemoglobin (tHb) and the difference between O2Hb and HHb [Hbdiff = O2Hb -HHb] of the dorsal lateral prefrontal cortex (DLPFC). To correct for scattering of photons in the tissue, a differential path-length factor (DPF) of 4.0 will be used, for the calculation of absolute concentration changes at a sample frequency of 10Hz. The NIRS probe will be placed in the Brodmann 46 region on the right DLPFC, which has been proposed to be more involved in regulating muscle fatigue and activation. Subsequently, the NIRS probe will be fixed with adhesive tape and a dark elastic bandage around the head to avoid external light and artifacts. The O2Hb, HHb and tHb will be used as an indicator of DLPFC total activity, while the Hbdiff (i.e., oxygen supply vs demand) will be used as a marker of oxygenation in the DLPFC. |
2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
|
|
Gait initiation - balance
Time Frame: 2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
|
Using two force plates in line the participant stands on the first, adapting a quite bipedal stance and after a verbal command, starts ambulating forwarding one leg and stepping on the second plate. GRFs are calculated from both force plates, to evaluate the balance ability single leg stance (Fy+Fx) |
2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
|
|
Gait initiation - acceleration
Time Frame: 2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
|
Using two force plates in line the participant stands on the first, adapting a quite bipedal stance and after a verbal command, starts ambulating forwarding one leg and stepping on the second plate. GRFs are calculated from both force plates, to evaluate foot clear force (FZ) respectively (leg .1) |
2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
|
|
Walking kinematic parameters - stride length
Time Frame: 2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
|
Ground reaction force (GRF) data captured at 1000 Hz for the right and left leg by the force platforms will be synchronized with the kinematic data obtained by the Vicon motion analysis system at 1000 Hz.
Kinematic data will focus on stride length and time and shoulder-pelvis association.
|
2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
|
|
Walking kinematic parameters - shoulder-pelvis association
Time Frame: 2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
|
Kinematic data obtained by the Vicon motion analysis system at 1000 Hz will focus on shoulder-pelvis association.
|
2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
|
|
Walking kinematic parameters - gait velocity
Time Frame: 2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
|
Kinematic data obtained by the Vicon motion analysis system at 1000 Hz and will focus on gait velocity.
|
2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
|
|
Walking kinetic parameters - medio-lateral ground reaction forces
Time Frame: 2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
|
GRFs are calculated from both force plates, to evaluate the medio-lateral movement during the stance phase of walking (Fy+Fx)
|
2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
|
|
Walking kinetic parameters- foot strike
Time Frame: 2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
|
GRFs are calculated from both force plates, to evaluate the strike forces during landing (Fz)
|
2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- YKCK2019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
Bezmialem Vakif UniversityRecruitingParkinson Disease | Parkinson | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseTurkey (Türkiye)
-
CND Life SciencesDigestive Disease Associates of CTRecruitingParkinson Disease | Parkinson | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
San Francisco Neurology and Sleep CenterNot yet recruitingPARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Haukeland University HospitalUniversity of Bergen; SPARK NSRecruitingParkinson Disease (PD) | Parkinson s DiseaseNorway
-
CND Life SciencesOregon Health and Science UniversityRecruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism | PARKINSON DISEASE (Disorder)United States
-
Università degli Studi dell'InsubriaUniversidade Nova de Lisboa; Associazione Parkinson Insubria (AsPI), Section... and other collaboratorsRecruitingParkinson Disease | Parkinson | Parkinson Disease, Idiopathic | PARKINSON DISEASE (Disorder)Italy
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic and other collaboratorsNot yet recruitingGut Microbiota | Gut Microbiome | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Prodromal Parkinsons DiseaseUnited States
-
ProgenaBiomeWithdrawnParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
Clinical Trials on Musicokinetic Training
-
Northeastern UniversityOregon Health and Science University; University of California, RiversideRecruiting
-
University of Trás-os-Montes and Alto DouroCompletedLipid Metabolism Disorders | Sarcopenia | Osteoporosis | Overweight and Obesity | Personal Satisfaction | Hypertension With Complications and Secondary HypertensionPortugal
-
New Jersey Institute of TechnologyRutgers, The State University of New JerseyCompletedHemiplegia | Hemiparesis | Cerebrovascular AccidentUnited States
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedHypertension | Diabetes | Peripheral Arterial DiseaseBrazil
-
Recep Tayyip Erdogan UniversityThe Scientific and Technological Research Council of TurkeyCompletedAthletic PerformanceTurkey (Türkiye)
-
Foundation for Atlanta Veterans Education and Research...United States Department of Defense; NYU Langone Health; University of Rochester and other collaboratorsRecruitingStress Disorders, Post-TraumaticUnited States
-
Lebanese UniversityCompletedHeart Failure | Quality of Life | Cardiac Rehabilitation | Aerobic Exercise | Exercise Intolerance | Respiratory Muscle Training | Strength Training
-
Poznan University of Physical EducationPoznan University of Medical Sciences; National Science Centre, PolandActive, not recruitingHealthy Athletes Aged 18-35 YearsPoland